Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > MedX was able to attract funding
View:
Post by rags2rags on Oct 27, 2022 3:27pm

MedX was able to attract funding

MedX was able to attract investors despite the current share price. Included among the investors was Forest Lane Holdings Limited, a company controlled by David Hennigar, a director of the Company, which subscribed for ten Series III Notes for a total of $500,000. I think the current share price is based on the belief that MedX is going out of business and that the current contracts are not producing any revenue. Over the next quarter if this proves to be a false belief, then I would expect the share price to have a solid rebound. The company is currently trading at 10% of tax-loss value, so for $4 million, you can buy a complete secure teledermatology platform, a Class 2 medical device with regulatory clearances in 38 countries. This is either extremely undervalued or a tax write-off.
Comment by Rubberband on Nov 17, 2022 10:13pm
Someone is pushing this hard to get it back to .07 cents. Bet next week easily. Rubberband
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities